Skip to main content
Addgene

RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis.

Wang ME, Chen J, Lu Y, Bawcom AR, Wu J, Ou J, Asara JM, Armstrong AJ, Wang Q, Li L, Wang Y, Huang J, Chen M
J Clin Invest. 2023 Mar 16:e166647. doi: 10.1172/JCI166647. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
202511pGL3-ACSL4-(-706/-277)Expressing luciferase driven by human ACSL4 promoter (bases -277 to -706 with respect to exon1 start site)
202512pGL3-ACSL4-(-254)Expressing luciferase driven by human ACSL4 promoter (bases -1 to -254 with respect to exon1 start site)
202513pGL3-ACSL4-(-706)Expressing luciferase driven by human ACSL4 promoter (bases -1 to -706 with respect to exon1 start site)
202514pGL3-ACSL4-(-1899)Expressing luciferase driven by human ACSL4 promoter (bases -1 to -1899 with respect to exon1 start site)
202515pGL3-ACSL4-FLExpressing luciferase driven by human ACSL4 promoter (bases -1 to -2844 with respect to exon1 start site)
202516LentiCRISPR v2 RB1 sgRNA #1Expressing Cas9 and sgRNA targeting human RB1 gene
202519LentiCRISPR v2 RB1 sgRNA #2Expressing Cas9 and sgRNA targeting human RB1 gene
202520pCMV-Tag2B-E2F1Expressing human E2F1 protein with FLAG-tag
202521pCMV-Tag2B-E2F2Expressing human E2F2 protein with FLAG-tag
202522pCMV-Tag2B-E2F3Expressing human E2F3 protein with FLAG-tag

Antibodies from Article